Synonyms: compound 9 [PMID: 33078933]
Compound class:
Synthetic organic
Comment: GLPG4716 (formerly OATD-01) is a first-in-class, orally bioavailable inhibitor of the chitinase enzymes chitinase 1 (chitotriosidase; CHIT1) and AMCase (chitinase acidic; CHIA) [1]. Galapagos have in-licensed the rights to develop this compound from OncoArendi/Molecure. GLPG4716 was developed as a treatment for respiratory diseases, having demonstrated efficacy in in vivo models of asthma and pulmonary fibrosis, and sarcoidosis. In mid-2022 the Galapagos/Molecure partnership was terminated and all rights for OATD-01 were returned to Molecure.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel